Premature Ejaculation: State of the Art
Section snippets
Diagnostic and Statistical Manual of Mental Disorders and International Classification of Diseases definition of premature ejaculation
Currently, there are two official definitions of PE. In the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), which is issued by the American Psychiatric Association, premature ejaculation is defined as a “persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it. The clinician must take into account factors that affect duration of the excitement phase, such as age, novelty of the sexual partner
Proposal for new definition of premature ejaculation
Recently, a new proposal for the pending DSM-V and ICD-11 definition of PE has been put forward [6], [7]. According to this proposal, PE should be classified according to a “syndromal” approach, incorporating well-controlled clinical and epidemiologic stopwatch studies [6]. PE as a clinical entity or a syndrome has for the first time been described by Schapiro in 1943 [8]. He distinguished Types A and B that were later termed “lifelong” and “acquired” PE by Godpodinoff [9]. Both types have been
Continuum of neurobiology and psychology
The distinction of the four PE syndromes shows a continuum of PE along a line from mainly neurobiologically to mainly psychologically determined forms (Fig. 1). For example, from both human and animal research it may be derived that lifelong PE is presumably highly neurobiologically and perhaps also genetically determined. However, as yet, one cannot rule out that certain forms of lifelong PE are psychologically determined. As is the case in major depression, a biologic marker of lifelong PE
Prevalences
Epidemiologic research has repeatedly shown a prevalence of PE of 20% to 30% [14]. Erroneously, by not distinguishing PE as a complaint and as a syndrome, it has been concluded that the “disorder” PE has a high prevalence. However, these studies have only shown that the “complaint” of PE in the general male population has a high prevalence of 20% to 30%. Studies into the prevalence of lifelong PE and acquired PE have never been conducted. However, it is of note that the prevalence of lifelong
Pathophysiology
The distinction of the four PE syndromes illustrates that there is not one particular pathophysiology of PE, but that there a different pathophysiologies dependent on the type of PE. For example, the serotonin hypothesis of PE, that is, a disturbance of serotonin neurotransmission and/or serotonin receptor functioning [15], pertains only to lifelong PE and partly to acquired PE. In other words, the serotonin hypothesis explains probably only a small percentage (2%–5%) of complaints of PE in the
Diagnosis of premature ejaculation syndromes
Lifelong, acquired, natural variable PE, and premature-like ejaculatory dysfunction are recognizable by taking a brief medical and sexual history with special attention to the duration of the ejaculation time, the frequency of occurrences, and the course since the first sexual encounters. In daily clinical practice, diagnosis of the four PE syndromes is not difficult, and therefore, evaluation with questionnaires or the use of a stopwatch is not required [4]. However, for drug treatment trials
Treatment
The distinction of the four PE syndromes has consequences for treatment. Lifelong PE should be treated with drugs that strongly delay ejaculation. It is a matter of debate whether additional counseling is always needed for these men. A lot of these men will manage without additional counseling. However, clinicians should take time to talk with these men, to inform them about the current knowledge of lifelong PE, and to regularly check their well-being, particularly when using SSRIs on a daily
Evidence-based drug treatment
Apart from randomized, double-blind controlled study designs, drug treatment studies of PE should include a baseline and a drug treatment period in which the IELT is measured prospectively at each coitus using a stopwatch handled by the female partner. The IELT is expressed in seconds or minutes, and in case an ejaculation occurs outside the vagina (ejaculatio ante portas), the IELT is by definition equal to zero. As the IELT distribution is positively skewed, IELT values should be
Daily selective serotonin reuptake inhibitor treatment
During the last decade, daily use of SSRIs, on-demand use of the tricyclic antidepressant clomipramine, and topical use of anesthetics has become most popular to treat PE [16]. Although none of these treatment options have been approved by the Food and Drug Administration, their use has been recognized and is supported by evidence-based studies [16]. The serotonergic antidepressants modify the course of PE by modulating the central serotonergic system, and the anesthetics suppress the
Summary
The DSM-IV-TR definition has a high risk for false-positive diagnoses of PE. Recently, a new classification of four PE syndromes has been proposed for the pending DSM-V. According to this classification PE can no longer be defined in one overall descriptive definition, but should be defined according to the symptomatology of the underlying PE syndrome.
The high prevalence rate of 20% to 30% is more likely to reflect the percentage of men that has “complaints” of PE, rather than the percentage of
References (38)
- et al.
Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part I: validity of DSM-IV-TR
J Sex Med
(2006) - et al.
Premature ejaculation: an observational study of men and their partners
J Sex Med
(2005) - et al.
Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II: proposals for DSM-V and ICD-11
J Sex Med
(2006) The need for a revival of psychoanalytic investigations into premature ejaculation
Journal Men's Health & Gender
(2006)Premature ejaculation: a review of 1130 cases
J Urol
(1943)- et al.
Prevalence of chronic prostatitis in men with premature ejaculation
Urology
(2001) The neurobiological approach to premature ejaculation
J Urol
(2002)- et al.
Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies
J Sex Med
(2007) - et al.
Majority of men with lifelong premature ejaculation prefer daily drug treatment: an observational study in a consecutive group of Dutch men
J Sex Med
(2007) - et al.
Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation
J Urol
(1995)
Clomipramine and sexual function in men with premature ejaculation and controls
J Urol
On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment
Eur Urol
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials
Lancet
Intracavernous medication for treatment of premature ejaculation
Urology
Diagnostic and statistical manual of mental disorders. 4th edition, Text Revision. DSM-IV-TR
The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research
Premature ejaculation: definition and drug treatment
Drugs
Premature ejaculation: clinical subgroups and etiology
J Sex Marital Ther
Cited by (74)
Assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: A prospective study
2022, Revista Internacional de AndrologiaThe Comorbidity Between Premature Ejaculation and Erectile Dysfunction—A Cross-Sectional Internet Survey
2019, Sexual MedicineCitation Excerpt :The current study was designed in 2012 before the introduction of IELT for defining PE.6,7 Using the PEDT to diagnose PE without consideration of IELT may lead to overestimation.15 An investigation in an Italian population reported greater prevalence rates of PEDT-defined PE (18.5% vs 6.3%) and self-reported IELT <1 minute (12.4% vs 6.4%, respectively) compared with those of the current study.9
Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis
2015, UrologyCitation Excerpt :Further understanding of ejaculation control mechanisms may prove beneficial to interpret the basic rationale of PDE-5 inhibitors for PE. PDE-5 inhibitors could inhibit the contractile response of the vas deferens, seminal vesicle, prostate, and urethra via nitric oxide/cyclic guanosine monophosphate pathway because of the expression of PDE-5 messenger RNA.25 Therefore, PDE-5 inhibitors could extend the total duration of erection and decrease the central sympathetic output.
Do Psychogenic Erectile Dysfunction and Premature Ejaculation Share a Neural Circuit? Evidence from a fMRI Systematic Review and Meta-Analysis
2022, Applied Sciences (Switzerland)